This report is free. No credit card required.
What you will learn when you read What is Nanotechnology? Nanotech Applications and Nanotech Investing
What about the nanotechnology companies that are focused on nanotechnology in medicine? Some of the companies we highlight include:
ASX-listed Starpharma is up nearly 40 percent year-to-date, is focused on products for pharmaceutical and life science applications. Starpharma’s share price rose in May when it announced that AstraZeneca had extended its collaboration agreement. AstraZeneca signed a license agreement with Starpharma for the use of its DEP® drug delivery platform in the development and commercialization of oncology compounds.
NanoViricides is developing nanotechnology-based anti-viral medicines, targeting influenza, HIV/AIDS, herpes and dengue fever, among others. NanoViricides is down about 57 percent year-to-date, currently sitting at $1.17. However, they haves a strong cash position and a low burn rate, and that a large amount of risk could be removed soon.
Arrowhead is developing RNAi therapeutics using small nanoparticles. Arrowhead nominated its first therapeutic candidate delivered using a new DPC designed to target tissues outside of the liver. “Preclinical data using our new extrahepatic DPC™ delivery system has been very promising,” said Arrowhead President and CEO Christopher Anzalone.
In all, there simply is no other single resource that brings together the best current information on nanotechnology investing, whether you’re a novice nanotech investor or an old hand. This free Special Report, What is Nanotechnology? Nanotech Applications and Nanotech Investing, is just what you need to find the very, very small things that will be very big news! Download it today!
And at this price – $0.00 – it’s certainly affordable! Don’t waste another minute wondering what investment opportunities underlie the bitcoin rate or in trying to sift through the onslaught of information – some of it valuable, much of it not – on your own. Read our Special Report today, and start making savvy investing decisions tomorrow!
We’re pleased to be able to make it available to you at no cost, and hope you’ll take advantage of the expertise it delivers.
Yours for profitable nanotech investing,
Publisher & CEO
Investing News Network
PS: Did I mention that this Special Report also includes numerous links to additional insight – information you might never find on your own? This is the kind of guidance that’s a deal at any price — but especially when it’s FREE. Download it today!
PPS: Here at Nanotech Investing News, we have no hidden, vested interest in getting you to invest in tech companies. We simply believe investors like you deserve the best professional guidance available, and we just happen to deliver it for free in this Special Report. Read it now!